Clinical trial
Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate…
NCT00264914 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00264914 |
|---|---|
| Title | Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Official title | An Open-Label, Multicenter Study Evaluating the Long-Term Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Acronym | SIADH Safety |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Inappropriate ADH Syndrome, Hyponatremia |
| Intervention type | Drug |
| Interventions | SR121463B |
| Enrollment | 57 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Dec 13, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | Australia, Belgium, Brazil, Canada, France, Germany, Hong Kong, Hungary, Russia, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: